AVITA Medical gains as USFDA greenlights Recell Go mini product

AVITA Medical

23/12/2024 23:42

** ASX-listed shares of Australia's AVITA Medical  AVH.AX 
 RCEL.O  rise as much as 7.9% to A$4.11
    ** Stock set for strongest trading session since early Nov
and hits highest since Dec. 12
    ** Co says U.S. Food and Drug Administration granted
approval for its Recell Go mini product
    ** The product is a mini disposable cartridge designed to
treat smaller wounds
    ** Stock had fallen 11.2% this year, as of last close

 (Reporting by Rishav Chatterjee in Bengaluru)
 ((Rishav.Chatterjee@thomsonreuters.com;))